Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

0
Player Avatar pchop123 (79.69) Submitted: 11/21/2012 3:46:50 PM : Underperform Start Price: $1.48 CHTP Score: -10.90

do not like the financial numbers here, especially on the cash flow

Featured Broker Partners


Advertisement